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Introduction 
Postoperative pericardial effusion following 
cardiac surgery is a frequent complication. There 
is no specific algorithm for the treatment of 
pericardial effusion post-cardiac surgery [1]. 
Pericardial effusion, in most cases, is mild and 
resolves spontaneously; however, 0.8-6% become 
clinically significant and necessitate intervention 
[2]. Despite the recent improvements in operative 
and postoperative management, late pericardial 
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Abstract 
Background: Pericardial effusion and tamponade are common following valve 
surgery. The optimal treatment of symptomatic pericardial effusions remains 
controversial. The objective of this study was to present our experience in non-
surgical management of delayed postoperative pericardial effusion. 
Methods: This retrospective study was conducted on 64 patients who had delayed 
pericardial effusion after cardiac surgery from 2016 to 2020. Eight patients 
were excluded due to the presence of inaccessible posterior or clotted pericardial 
effusion and were managed surgically, and 56 patients had percutaneous 
drainage of the pericardial fluid and were included in the analysis.  
Results: The mean age was 46.84±11.67 years (range: 22- 68 years), and 46.43% 
were females. The patients had coronary artery bypass grafting (n= 9), Aortic valve 
replacements (n= 13), Mitral valve surgery (n= 21), double valve replacements (n= 8) 
and combined procedures (n= 5).  All patients complained of varying degrees of 
exertional dyspnea. There were statistically significant differences between INR in 
different cardiac surgeries. Mean INR following mitral valve replacement (4.72±0.63) 
was significantly higher than in aortic valve replacement patients (3.32±0.34; 
p<0.001) and aortic valve patients (1.76±0.24; p<0.001). Fifteen patients (26.78%) 
had a large pericardial effusion. Successful drainage was achieved in all cases. 
Compl ications were pneumothorax (n= 2, 3.57%), recurrent effusions (n= 4, 7.14%), 
arrhy thmias (n= 7, 12.5%), myocardial punctures (n= 2, 3.57%) and no mortality was 
reported.   
Conclu sions: Percutaneous drainage of postoperative pericardial effusion under 
radiological guidance is generally safe. Pericardial effusion is common after mitral 








Submitted: 20 Apr 2020 
Revised: 3 May 2020 
Accepted: 15 May 2020 
Published: 1 July 2020 
106 Sanad M 
effusions remain a significant cause of morbidity 
after cardiac surgery. Pericardial effusions may 
delay recovery and can be life-threatening when it 
causes tamponade with hemodynamic 
compromise [3].  
Postoperative pericarditis can occur as early as 
two weeks following surgery. Pericarditis often 
bears restrictive hemodynamic characteristics 
despite an open pericardium. The presence of 
blood in the pericardium may result in irritation 
of the serosal layer and inflammation [4].  
The optimal treatment of symptomatic 
pericardial effusions remains controversial. The 
ideal treatment strategy would include complete 
drainage of the effusion with minimal procedural 
mortality [5].   
Surgical pericardial drainage via reopening the 
subxiphoid part of the wound is technically 
straightforward. It offers a view of the inferior 
pericardial space, plus it permits drainage of blood 
clots in the effusion. However, general anesthesia 
is required with its risk, and reopening the wound 
could contaminate the pericardial space [6]. 
Although transthoracic echocardiography 
(TTE) is the preferred first-line modality for 
evaluating postoperative pericardial effusion, 
computed tomography of the chest (CT) often 
allows a thorough assessment. This technique is 
superior to echocardiography for accurate 
detection of the small amount and localization of 
the fluid. Characterization of the pericardial fluid 
by measuring attenuation values on CT images is 
valuable. Additionally, CT imaging enables an 
accurate illustration of the pericardial layers, with 
an assessment of thickness and composition [7]. 
In this study, we present our experience in non-
surgical management of delayed postoperative 
pericardial effusion in our university hospital. 
Patients and Methods: 
Study design and setting: 
This retrospective study was conducted from 
January 2016 till January 2020. We included 
patients presented with delayed post-cardiac 
surgery pericardial effusion, defined as effusion 
occurring after 15 days of surgery. The medical 
records were retrospectively reviewed for clinical 
presentation, surgical maneuver, imaging 
modalities, procedural details, and outcomes.  A 
phone call to the patients was used to complete 
the missing data. 
Inclusion and exclusion criteria: 
We included adult patients with symptomatic 
post-cardiac surgery pericardial effusion 
accessible for percutaneous drainage. We 
excluded patients who underwent surgical 
exploration due to loculated effusion, presence of 
blood clots, inaccessible posterior collection, or 
failed catheter drainage. Patients with heart 
failure were excluded as they were medically 
treated. Stable patients with the proved post-
pericardiotomy syndrome were managed 
medically by colchicine and other anti-
inflammatory medications. 
Ethical considerations: 
We followed the declaration of Helsinki 
regarding studies on human subjects [8]. 
Approvals of the Institutional Research Board 
were obtained. Informed written consent was 
obtained from all cases after the explanation of
Figure 1: Transthoracic echocardiography showing massive pericardial effusion. 
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Figure 2: Multi-slice CT chest with intravenous contrast showing: Panel A: Massive circumferential pericardial effusion 
with access laterally and to the left in the anterior axillary line. Panel B: following complete pericardial drainage of 
the same patient.
 the details of both percutaneous intervention and 
the possible need for surgical intervention with 
full information about possible complications. 
Consent to participate in the study was waived 
because of the retrospective nature of the 
research. 
Surgical workup and approach: 
All patients were discharged after their initial 
surgery with acceptable echocardiography and 
targeted international normalized ratio (INR). All 
patients had regular follow-up after one month of 
the procedure at the outpatient clinic.  
Patients with pericardial effusion presented to the 
outpatient clinic or the emergency department if 
hemodynamically unstable.  
Clinical suspicion of having pericardial 
collection was based on the development of 
dyspnea, orthopnea, palpitation, nausea, and 
occasionally vomiting. A thorough examination for 
these patients included: heart rate, blood pressure 
measurement, assessment of neck veins, heart 
sounds, edema of the lower limbs, and chest 
auscultation for rales. A chest X-ray was the initial 
test in most patients.  
The final diagnosis was confirmed in all cases 
with echocardiography (Figure 1). CT chest with 
contrast was done for all stable patients with 
acceptable kidney function tests (Figure 2A). INR 
was tested routinely for all patients whether they 
were on warfarin therapy or not, plus other 
laboratory investigations included a complete 
blood picture (CBC), liver and renal function tests, 
random plasma glucose, and acute phase 
reactants. 
Non-emergent patients with uncontrolled INR 
and coagulopathy were controlled before doing 
the invasive maneuver. Fresh frozen plasma (FFP) 
transfusion was sufficient. Vitamin K injection was 
reserved for unstable cases with warfarin toxicity.  
Drainage of postoperative pericardial effusion was 
done by percutaneous placement of an indwelling 
pericardial catheter. Catheter drainage was 
suitable for moderate to large anteriorly and 
anterolateral effusion (Figure 2A, Figure 3). The 
entirely located posterior collection was not 
amenable for catheter drainage. Some cases with 
the posterior collection but extended laterally or 
basally were approached but with more caution.
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Figure 3: Multi-slice CT chest without intravenous contrast showing a pigtail inserted via a subxiphoid approach for 
drainage of pericardial effusion.
 Indwelling catheters of sizes (7Fr- 10Fr- 12Fr) 
were applied using Seldinger's technique under 
echocardiographic guidance and prior CT 
assessment. The procedure was performed under 
full monitoring with access from the anterior 
chest wall, typically subcostal (Figure 3). Right or 
left parasternal access was used. The site of the 
collection was confirmed using a fine spinal 
needle. If the aspiration trial was proved to be 
hemorrhagic, cautions were done to exclude 
cardiac puncture by observation of 
electrocardiogram (ECG) changes on the monitor. 
Coagulation of the aspirate and rapid laboratory 
estimation of hemoglobin concentration in the 
aspirate was done and compared with the 
patient's hemoglobin. 
Postoperative management: 
Following the procedure, the cases were 
monitored in the cardiac surgery intensive care 
unit (ICU), then moved to the ward unless 
complications were anticipated. 
The catheter was removed after cessation of 
drainage in a hemodynamically stable patient with 
echocardiographic and radiologically proven total 
drainage of the pericardial effusion (Figure 2B). 
They were discharged with close follow up in the 
outpatient clinic.  
Study endpoints: 
The primary endpoint was the success of 
evacuation of the pericardial effusion. The 
secondary endpoints were the postprocedural 
morbidity and mortality. 
Statistical analysis: 
The data were tabulated and analyzed using 
IBM SPSS software version 25.0 (IBM Inc., Chicago, 
IL, USA). Qualitative data were described using the 
number and percent. Continuous quantitative 
variables were assessed for normality; normal 
variables were reported as mean and standard 
deviation (SD). One-Way Analysis of Variance 
(ANOVA) to compare means of more than two 
groups of the INR. Tukey HSD "Honestly Significant 
Difference" posthoc test was used. A p-value of 
0.05 or less indicates a statistically significant 
difference among the various groups. 
Results 
Sixty-four patients presented with 
postoperative pericardial effusion; eight patients 
who had surgical drainage were excluded. Fifty-
six patients had percutaneous drainage and were 
included in the analysis. The mean age was 46.84 
± 11.671 years (ranged from 22 to 68 years). They 
were 30 males (53.57%), and 26 were females 
(46.43%). The demographic data of the study 
sample are presented in (Table 1). All our cases 
who underwent valve replacement had received 
mechanical valves and were on warfarin 
treatment. 
All patients complained of exertional dyspnea 
and occasionally orthopnea. Additional symptoms 
were non-specific, including easy fatigability, 
palpitation, nausea, and vomiting (Table 2). INR 
at the time of admission ranged from 1.2 to 7 
(mean± SD: 3.57 ± 1.35). The mean INR was 1.76
±0.24 after CABG, 3.32±0.34 after aortic valve 
Sanad M 
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replacement (AVR), and 4.72±0.63 after mitral 
valve replacement (MVR). 
Table 1: Demographic data of the study sample. Data 
are expressed as mean and standard deviation or as a 
percentage and frequency 
(n= 56) 
Age (years) 46.84 ± 11.67 
Males 30 (53.57%) 
Diabetes Mellitus 16 (28.57%) 
Hypertension 27 (48.21%) 
Smokers (ex or current) 12 (14.63%) 
Dyslipidemia 9 (16.07%) 
Ischemic Heart Disease 13 (23.21%) 
Chronic Lung Disease 11 (19.64%) 
Postoperative renal failure 7 (12.5%) 
History of re-exploration for 
bleeding  
3 (5.35%) 




MVR - DVR 4.72±0.63 
Total  3.57±1.35 
CABG 9 (16.1%) 
AVR 13 (23.2%) 
DVR 8 (14.3%) 
MVR 16 (28.6%) 
MVR and TV repair 5 (8.9%) 
Combined 5 (8.9%) 
Time from discharge to 
readmission (days) 
19.39 ± 3.415 
CABG: Coronary artery bypass grafting; MVR: 
Mitral valve replacement; TVR: Tricuspid valve 
repair; DVR: Double valve replacement 
Posthoc comparisons indicated statistically 
significant differences between INR and the 
cardiac surgery performed (CABG vs AVR: 
Diff=1.5400, 95%CI=0.9652 to 2.1148, p<0.0001; 
CABG vs MVR: Diff=2.9400, 95%CI=2.4343 to 
3.4457, p<0.001; and AVR vs MVR: Diff=1.4000, 
95%CI=0.9576 to 1.8424, p<0.001).  
Timing from discharge to readmission varied 
from 15 to 28 days with a mean of 19.39 ± 3.415 
days (Table 1). The collection was large in 15 
cases (26.78%) depending on the 
echocardiography and CT studies, which showed 
fluid distribution and 
the widest area in cm and confirmed by the 
quantity of the drain. The nature of the fluid was 
serous in 24 cases (42.9%) and serosanguineous 
in 32 cases (57.1%) (Table 2). 
Table 2: Clinical signs, collection size, nature, and 
location of the pericardial collection. (Data are 
expressed as number and percent) 
(n= 56) 
Presenting symptoms 
Asymptomatic 4 (8.04%) 
Arrhythmia 13 (23.21%) 
Dyspnea / orthopnea 52 (92.86%) 
Hypotension 48 (85.71%) 
Easy fatigue 27 (48.21%) 
Fever 4 (7.14%) 
Oliguria 17 (30.38%) 
Chest pain 6 (10.71%) 
Vomiting 8 (14.29%) 
Unstable patients 12 (21.4%) 
Collection size 
Moderate 41 (73.2%) 
Severe 15 (26.8%) 
Nature of the fluid 
Serous 24 (42.9%) 
Serosanguinous 32 (57.1%) 
Location 
Anterior 5 (8.9%) 
Anterolateral to the left 7 (12.5%) 
Anterolateral to the right 6 (10.7%) 
Lateral right 12 (21.4%) 
Lateral left 9 (16.1%) 
Basal 10 (17.9%) 
Diffuse 7 (12.5%) 
Previous surgery performed was CABG (n= 9), 
AVR (n= 13), double aortic and mitral valve 
replacement (n= 8), mitral valve replacement (n= 
16), mitral valve replacement and tricuspid valve 
repair (n= 5), combined valvular and CABG surgery 
(n= 5). Twelve patients presented with tamponade 
and were unstable. They were admitted to the 
ICU, stabilized firstly, and we proceeded rapidly in 
echo guided insertion of an indwelling catheter 
for drainage (Table 2).   
Two patients developed pneumothorax; one 
required chest tube drainage for two days. The 
second patient had minimal pneumothorax with a 
stationary course over the next 24 hours and was 
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managed conservatively  (Table 3). Three patients 
(5.36%) needed pleural drainage and were 
performed immediately after the tube 
pericardiotomy. Four patients developed 
recurrent effusion and required reinsertion of the 
catheter. One patient with AVR returned for the 
third time despite controlled INR and had surgical 
exploration. Intraoperatively there was no active 
bleeding (Table 3). 
Table 3: Needle entry and complications of aspiration. 
(Data are expressed as number and percent) 
(n= 56) 
Needle entry 
Right parasternal 11 (19.6%) 
Left parasternal 12 (21.4%) 
Subxiphoid 33 (58.9%) 
Arrhythmia 7 (12.5%) 
Right internal mammary 
hematoma 
1 (1.8%) 
Pneumothorax 2 (3.6%) 
Recurrence 4 (7.1%) 
Exploration 1 (1.8%) 
Myocardial puncture 2 (3.57%) 
One patient had small opacity after full 
drainage; it was proved radiologically to be 
concealed right internal mammary vessels 
hematoma, about 2X3 cm with no adverse effect. 
Seven patients developed transient 
supraventricular tachycardia during needle 
insertion.    Accidental needle puncture of the 
heart was reported in 2 cases and was 
conservatively managed. No mortality was 
recorded. Complete pericardial drainage was 
achieved in all cases 
Discussion 
Pericardial effusion is common after cardiac 
surgery and reaches its peak at the end of the first 
postoperative week. The risk of early cardiac 
tamponade is well-acknowledged, but the 
incidence of late cardiac tamponade is probably 
underestimated [9].  There is no sharp definition 
of timing of postoperative pericardial effusion; we 
considered late postoperative pericardial effusion 
as the effusion occurring two weeks after surgery. 
We had 56 patients with significant delayed 
postoperative pericardial effusion presented to 
our institution for over four years. All CABG 
patients were discharged on dual anti-platelet 
treatment; however, none of them had significant 
thrombocytopenia, and thrombasthenia could not 
be excluded. 
Subxiphoid pericardial drainage is the 
preferred technique because of a lower risk of 
complication and recurrence. In postoperative 
cardiac surgery, the physiopathology of the 
effusion is different, and there is little data about 
the results of both surgical and catheter drainage 
techniques in the literature [6]. 
The open approach allows the surgeon to 
break the loculations and place a larger tube for 
enhanced drainage. On the other hand, 
percutaneous drainage usually can be 
accomplished without general anesthesia. As a 
result of these mixed attributes, there is 
widespread disagreement among surgeons about 
the ideal procedure for PE drainage [5].   
Palmer and coworkers [2] reported 83% of 
patients had sanguineous or serosanguineous PE, 
and the remaining had clear serous fluid. We 
reported 32 cases of serosanguineous collection 
and 24 cases of serous effusion. 
We have 16 cases of mitral valve replacement 
plus 5 cases of mitral valve replacement and 
tricuspid valve repair; both collectively represent 
37.5% of cases. The intended higher levels of INR 
(2.5-3.5) may be an explanation of this high 
percentage. The mean INR in mitral valve 
replacement cases was 4.7. 
For patients who had hemorrhagic effusions 
and high INR values, the pathophysiology of 
effusions in these patients is proposed that high 
peaks in INR values causing prolonged oozing into 
the pericardial cavity is the commonly accepted 
theory. Wong and Pugsley postulated that 
congestion of the liver owing to right heart failure 
or tamponade physiology might be the triggering 
factor for high INR values in these patients. In our 
study, there was a significant relationship 
between the degree of INR and the occurrence of 
hemorrhagic effusion. Still, this relationship is not 
clear enough, and we had cases of CABG who were 
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not on warfarin therapy and developed 
hemorrhagic effusion. 
Early postoperative liver dysfunction 
secondary to cardiopulmonary bypass may result 
in bouts of INR elevation shortly after patient 
discharge. At that time, the process of oozing of 
bloody exudate within the pericardium will start, 
and once started, it will irritate the pericardium 
even after regaining hepatic function and normal 
range of INR. 
Chest X-ray was the initial investigation in all 
patients, and the diagnosis was confirmed with 
echocardiography, which gave details about the 
presence of the effusion, its size, site, and nature. 
All stable patients were re-evaluated with a CT 
chest with contrast, which accurately estimated 
the site of the fluid and the nearest point for 
needle insertion, also the vulnerability of the 
pleura to the puncture. CT imaging helped to 
choose the most appropriate point for trial 
aspiration using a small-caliber syringe initially to 
confirm site accessibility and then proceed with 
Seldinger's technique for insertion of the catheter 
safely. 
The subxiphoid approach for catheter 
insertion seemed the best being away from both 
lungs and the mammary vessels; there is the only 
risk of right ventricular injury. Thirty-three 
patients (58.9%) were drained through a catheter 
inserted through the subxiphoid approach, while 
12 patients (21.4%) were done via the left 
parasternal approach and the remaining 11 
patients (19.6%) were done via the right 
parasternal approach. Jaussad and coworkers 
performed the postoperative pericardial effusion 
catheter drainage by subxiphoid puncture (91.9%) 
or left parasternal puncture (8.1%). 
Although CABG surgery represents more than 
fifty percent of all our surgical cases, only nine 
patients (16%) were included in this study. It is 
obvious that most cases of early postoperative re-
exploration for bleeding are CABG cases, but they 
rarely present with delayed pericardial effusion. It 
may be the elevated INR related to warfarin 
therapy is the actual cause of delayed PE. 
Additionally, the widely opened left pleura in most 
of our cases probably guarded against pericardial 
collection; instead, they developed left pleural 
effusion.  
None of our cases were re-operative surgery; 
the presence of adhesions may explain this. 
Recurrent pericardial effusion occurred in 4 
patients (7.1); three of them had percutaneous 
drainage, while the 4th one had serosanguineous 
effusion and was explored surgically.  Palmer and 
associates [2] reported three of 36 patients (8%) 
had recurrent effusions; one of them was heart 
transplantation with signs of rejection, and the 
other was Dressler syndrome.  
Seven cases suffered from procedural related 
arrhythmias. All of these were supraventricular 
tachycardia, occurred during needle entry. They 
were self-limiting and subsided once the needle 
was withdrawn. No subsequent myocardial 
laceration with active bleeding was reported. In 
cases of significant lateral effusion, the process of 
catheter insertion through the intercostal space 
was straightforward. It resulted in minor 
complications; stationary 2X3 cm right internal 
mammary vessels hematoma and two patients 
had a pneumothorax.  
Ashikhina and coworkers [10] studied a large 
group of 327 patients and found that pericardial 
effusion occurred in 1.5% of patients and the 
independent risk factors for effusion were larger 
body surface area, hypertension, 
immunosuppression, renal failure, pulmonary 
thromboembolism, prolonged cardiopulmonary 
bypass and cardiac operation other than coronary 
artery bypass grafting. Previous cardiac operations 
were associated with a lower risk of effusion, and 
echocardiography-guided pericardiocentesis is 
effective and safe in these patients [11 – 13]. 
Ashikhina and collaborators [10] and Hernandez 
and colleagues [11] described non-coronary 
artery surgery as a risk factor for delayed 
postoperative PE plus full pre or postoperative 
anticoagulation, need for RBC transfusion, and 
surgical reintervention in the first 48 h following 
surgery [11, 14, 15]. 
We had no procedure-related mortality. 
Jaussad and coworkers [6] reported no mortality 
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among their 197 patients. Kolek and Brat [16] 
found that initial echo-guided pericardiocentesis 
was therapeutically effective in 98.6% of cases, 
and the rate of major complications was 1%. There 
was no mortality related to the procedure, and 18 
patients (8.7%) required repeated 
pericardiocentesis due to recurrent effusion, while 
15 patients (7.2%) required surgery due to 
recurrent effusion or failed maneuver.  
Nour-Eldin and coworkers [17] included 128 
consecutive patients complicated with pericardial 
effusion or hemopericardium after cardiac surgery 
in 8 years. The medical indication for therapeutic 
pericardiocentesis in all patients was 
hemodynamic instability. The treatment criteria 
for intervention were evidence of pericardial 
tamponade with ejection fraction <50%. 
Pericardiocentesis and placement of a 
percutaneous pericardial drain were technically 
successful in all patients. Directly after 
pericardiocentesis, there was a significant 
improvement of the ejection fraction to 40-55%. 
The drainage was applied anteriorly 
(periventricular) in 39 of 128 (30.5%), retro-
ventricular in 33 of 128 (25.8%), and infra-cardiac 
in 56 of 128 (43.8%). The recurrence rate of 
pericardial effusion after the removal of drains 
was 4.7% (67/128). Complete drainage was 
achieved in retro-ventricular and infra-cardiac 
positioning of the catheter. Recorded 
complications included minimal asymptomatic 
pneumothorax and pneumomediastinum 2.3% 
(3/128) and sinus tachycardia 3.9% (5/128). This 
comes in agreement with our results and success 
rate. 
Study limitations 
The study comprises results from one referral 
center. The sample did not test the effect of 
different anticoagulants or antiplatelets. Our 
sample did not include cases with ascending aortic 
replacement. A larger sample and longer follow up 
are needed. 
Conclusion 
Percutaneous drainage of postoperative 
pericardial effusion under radiological guidance is 
generally safe. Pericardial effusion is common 
after mitral valve surgery, which could be related 
to higher target INR in these patients. 
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